Join
Live feed
·
PRReleasevia Quantisnow
Ironwood Pharmaceuticals Inc. logo

FDA Approves Use of LINZESS® (linaclotide) in Pediatric Patients Two Years of Age and Older with Functional Constipation (FC)

ByQuantisnow·Wall Street's wire, on your screen.
IRWD· Ironwood Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IRWD (Ironwood Pharmaceuticals Inc.) and more on Quantisnow.